India notifies first policy on rare diseases
India notifies first policy on rare diseases The policy comes over three years after the health ministry formulated a National Policy for Treatment of Rare Diseases in July 2017 but kept it in abeyance. In the new policy, formulated after detailed stakeholder consultations, 'rare diseases' have not been defined but classified into three groups based on expert opinion. https://ift.tt/eA8V8J
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
https://ift.tt/3rGmvuO https://ift.tt/1R552o9
 |
submitted by /u/DomPachino [link] [comments] |
EU drug watchdog reaffirms no particular clot risk factor linked to AstraZeneca vaccine
EU drug watchdog reaffirms no particular clot risk factor linked to AstraZeneca vaccine However, while repeating that the vaccine's benefits outweigh risks, it cautioned that people should be aware of the remote possibility of rare blood clots occurring, and must seek immediate medical attention in case of symptoms. https://ift.tt/eA8V8J
Subscribe to:
Posts (Atom)
Popular Posts
|
